Elias Jabbour1, Emma Searle2*, Maher Abdul-Hay, M.D.3*, Sameem Abedin, MD4, Ibrahim Aldoss, MD5, Ana Alfonso Piérola, MD, PhD6*, Juan Manuel Alonso-Dominguez, MD, PhD7*, Patrice Chevallier, MD8, Carrye Cost, MD9*, Nikki Daskalakis, MD9*, Richard Dillon, PhD, MRCP, FRCPath10*, Neil Dunavin, MD, MS11*, Jordi Esteve, MD, PhD12, Amir T. Fathi, MD13, Pasquale L. Fedele, MBBS, PhD, FRACP, FRCPA14*, Lucille Ferrante, MD, MS9, Sylvain Garciaz15*, Christina Guttke, PhD9*, Emmanuel Gyan16,17,18, Brett Hiebert, MS19*, Min Chul Kwon20, Jonathan Miller, MD, PhD21*, Teng Fong Ng, BSc, MBBS, MRCP, FRACP, FRCPA22*, Kathryn Packman, PhD23*, Ulrike Philippar, PhD20, Arnaud Pigneux, MD, PhD24*, Christian Recher, MD, PhD25*, Olga Salamero, MD26*, Madhu Sanga, PhD27*, Richard M Stone, MD28, Peter Tan, MBBS (Hons), Mphil, FRACP, FRCPA29*, Jan Willem Thuring, PhD20*, Trevor Tucker9* and Paresh Vyas, FMedSci, DPhil, FRCPath30*
1Department of Leukemia, MD Anderson Cancer Center, University of Texas, Houston, TX
2The Christie NHS Foundation Trust and University of Manchester, Manchester, United Kingdom
3Blood and Marrow Transplantation and Cellular Therapy, Laura and Issac Perlmutter Cancer Center at NYU Langone Health, New York, NY
4Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
5City of Hope National Medical Center, Duarte, CA
6Clínica Universidad de Navarra, Pamplona, Spain
7Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
8CHU de Nantes - Hôtel Dieu, Nantes, France
9Janssen Research & Development, LLC, Spring House, PA
10Guy’s Hospital and King’s College, London, United Kingdom
11University of California San Francisco, San Francisco, CA
12Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain
13Massachusetts General Hospital, Harvard Medical School, Boston, MA
14Haematology Department, Monash Health and School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia
15Hematology Department, Integrative Structural and Chemical Biology, Aix-Marseille Université, Inserm, CNRS, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille, France
16CHU de Tours, Service d'Hématologie & Thérapie Cellulaire, Centre Hospitalier Universitaire, Tours, France
17Equipe CNRS ERL9001 Leukemic Niche and RedOx Metabolism, Université de Tours, Tours, France
18Centre d'Investigation Clinique INSERM U1415, Centre Hospitalier Universitaire, Tours, France
19IQVIA, Winnipeg, MB, Canada
20Janssen Research & Development, LLC, Beerse, Belgium
21Janssen Research & Development, LLC, Raritan, NJ
22Gold Coast University Hospital, Southport, QLD, Australia
23Janssen Research & Development, LLC, Cambridge, MA
24Centre Hospitalier Universitaire de Bordeaux, Hôpital Haut Lévêque - Centre François Magendie, Pessac, France
25CHU de Toulouse, Institut Universitaire du Cancer Toulouse – Oncopole, Toulouse, France
26Department of Hematology and Experimental Hematology, Vall d’Hebron Institute of Oncology, University Hospital Vall d’Hebron, Barcelona, Spain
27Janssen Research & Development, LLC, Brisbane, CA
28Dana-Farber Cancer Institute, Boston, MA
29Royal Perth Hospital, Perth, Australia
30MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom